Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 9 studies | 32% ± 15% | |
oligodendrocyte | 8 studies | 28% ± 11% | |
basal cell | 7 studies | 23% ± 8% | |
adipocyte | 7 studies | 35% ± 21% | |
epithelial cell | 6 studies | 31% ± 13% | |
endothelial cell | 4 studies | 27% ± 18% | |
type I pneumocyte | 4 studies | 18% ± 3% | |
macrophage | 4 studies | 25% ± 7% | |
secretory cell | 3 studies | 22% ± 5% | |
ciliated cell | 3 studies | 26% ± 4% | |
fibroblast | 3 studies | 20% ± 5% | |
GABAergic neuron | 3 studies | 25% ± 4% | |
glutamatergic neuron | 3 studies | 29% ± 6% | |
goblet cell | 3 studies | 24% ± 10% | |
transit amplifying cell | 3 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9843.46 | 1439 / 1445 | 100% | 83.65 | 183 / 183 |
prostate | 100% | 10939.38 | 245 / 245 | 99% | 98.31 | 497 / 502 |
skin | 100% | 9686.10 | 1808 / 1809 | 99% | 65.32 | 465 / 472 |
thymus | 100% | 8011.65 | 651 / 653 | 99% | 68.05 | 597 / 605 |
breast | 99% | 12148.28 | 456 / 459 | 99% | 151.73 | 1106 / 1118 |
bladder | 100% | 8123.52 | 21 / 21 | 97% | 74.32 | 488 / 504 |
intestine | 100% | 9016.96 | 966 / 966 | 97% | 55.18 | 510 / 527 |
stomach | 99% | 5283.85 | 355 / 359 | 97% | 53.12 | 276 / 286 |
uterus | 99% | 7504.96 | 168 / 170 | 97% | 96.93 | 443 / 459 |
lung | 99% | 7481.62 | 575 / 578 | 96% | 61.38 | 1106 / 1155 |
adrenal gland | 100% | 55552.76 | 258 / 258 | 94% | 67.92 | 216 / 230 |
kidney | 99% | 5887.21 | 88 / 89 | 94% | 42.77 | 851 / 901 |
liver | 100% | 22242.08 | 226 / 226 | 93% | 63.92 | 378 / 406 |
brain | 97% | 6355.89 | 2570 / 2642 | 95% | 55.98 | 670 / 705 |
ovary | 100% | 9863.15 | 180 / 180 | 82% | 30.36 | 352 / 430 |
pancreas | 84% | 2426.55 | 274 / 328 | 93% | 39.20 | 165 / 178 |
spleen | 100% | 5099.38 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 131.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.47 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 99.80 | 79 / 80 |
adipose | 99% | 9212.51 | 1188 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 38.05 | 27 / 29 |
muscle | 93% | 4670.18 | 746 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 4890.68 | 1224 / 1335 | 0% | 0 | 0 / 0 |
heart | 86% | 3644.06 | 738 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 2627.42 | 727 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_1901524 | Biological process | regulation of mitophagy |
GO_0030324 | Biological process | lung development |
GO_1903214 | Biological process | regulation of protein targeting to mitochondrion |
GO_0009749 | Biological process | response to glucose |
GO_0003062 | Biological process | regulation of heart rate by chemical signal |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0019217 | Biological process | regulation of fatty acid metabolic process |
GO_0033762 | Biological process | response to glucagon |
GO_0008610 | Biological process | lipid biosynthetic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0009267 | Biological process | cellular response to starvation |
GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
GO_0045471 | Biological process | response to ethanol |
GO_0046676 | Biological process | negative regulation of insulin secretion |
GO_0007623 | Biological process | circadian rhythm |
GO_0090209 | Biological process | negative regulation of triglyceride metabolic process |
GO_0009750 | Biological process | response to fructose |
GO_0051591 | Biological process | response to cAMP |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0032933 | Biological process | SREBP signaling pathway |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0010883 | Biological process | regulation of lipid storage |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0030073 | Biological process | insulin secretion |
GO_0032526 | Biological process | response to retinoic acid |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0032094 | Biological process | response to food |
GO_0006629 | Biological process | lipid metabolic process |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0032570 | Biological process | response to progesterone |
GO_0045542 | Biological process | positive regulation of cholesterol biosynthetic process |
GO_0031647 | Biological process | regulation of protein stability |
GO_0045444 | Biological process | fat cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0032810 | Molecular function | sterol response element binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SREBF1 |
Protein name | Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)] Sterol regulatory element-binding protein 1 (Sterol regulatory element-binding transcription factor 1) Sterol regulatory element binding transcription factor 1 |
Synonyms | BHLHD1 SREBP1 |
Description | FUNCTION: [Sterol regulatory element-binding protein 1]: Precursor of the transcription factor form (Processed sterol regulatory element-binding protein 1), which is embedded in the endoplasmic reticulum membrane . Low sterol concentrations promote processing of this form, releasing the transcription factor form that translocates into the nucleus and activates transcription of genes involved in cholesterol biosynthesis and lipid homeostasis (By similarity). .; FUNCTION: [Processed sterol regulatory element-binding protein 1]: Key transcription factor that regulates expression of genes involved in cholesterol biosynthesis and lipid homeostasis . Binds to the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3'). Has dual sequence specificity binding to both an E-box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') . Regulates the promoters of genes involved in cholesterol biosynthesis and the LDL receptor (LDLR) pathway of sterol regulation . .; FUNCTION: [Isoform SREBP-1A]: Isoform expressed only in select tissues, which has higher transcriptional activity compared to SREBP-1C (By similarity). Able to stimulate both lipogenic and cholesterogenic gene expression . Has a role in the nutritional regulation of fatty acids and triglycerides in lipogenic organs such as the liver (By similarity). Required for innate immune response in macrophages by regulating lipid metabolism (By similarity). .; FUNCTION: [Isoform SREBP-1C]: Predominant isoform expressed in most tissues, which has weaker transcriptional activity compared to isoform SREBP-1A (By similarity). Primarily controls expression of lipogenic gene . Strongly activates global lipid synthesis in rapidly growing cells (By similarity). .; FUNCTION: [Isoform SREBP-1aDelta]: The absence of Golgi proteolytic processing requirement makes this isoform constitutively active in transactivation of lipogenic gene promoters. .; FUNCTION: [Isoform SREBP-1cDelta]: The absence of Golgi proteolytic processing requirement makes this isoform constitutively active in transactivation of lipogenic gene promoters. . |
Accessions | K7EMD1 K7EKR7 ENST00000577897.2 K7EMT8 ENST00000485080.6 ENST00000486311.5 ENST00000395757.6 [P36956-2] ENST00000478616.1 J3QLB6 K7EIW8 ENST00000261646.11 [P36956-1] ENST00000578469.1 ENST00000423161.3 P36956 ENST00000395756.5 F6V242 S4R3B4 ENST00000355815.8 [P36956-4] |